Augmenting the randomized controlled trial with real-world data: an interview with Michael Moran


In this podcast, we take a peek behind the paper with lead study author Michael Moran (Pfizer, Berlin, Germany) to discuss some of his research into the possibility of augmenting the randomized controlled trial with real-world data. Clinical trials are the ‘gold standard’, established way of gathering evidence to demonstrate the effectiveness of novel therapeutics, however, thereĀ are concerns that clinical trials do not fully represent those patients seen in everyday clinical practice. In this podcast, we take a peek behind the paper with lead study author Michael Moran (Pfizer, Berlin, Germany) to discuss research he was involved in concerning augmenting...

To view this content, please register now for access

It's completely free